Certified by Founder Lodge
Acorn Bioventures
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $108,000,000
2 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
We invest in and partner with private and small capitalization biotech, specialty pharma and medical device companies.
| Company | Date | Round | Raised |
|---|---|---|---|
Bicara Therapeutics |
March, 07 ,2023 | Series B | $108,000,000 |
Neuron23 |
June, 26 ,2025 | Series D | $96,500,000 |
Bicara Therapeutics
Neuron23
dezerv.
FalconX
Kristal.AI
Finary
Savart
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)